CatalystWireBeta

Victrex plc

VCT · Main Market · Chemicals · mcap £820m · 892.0p 2 open situations →

Beta Briefing, track record and signals & risks are not ready for Victrex plc yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 2

New CEO / reset

CEO succession

Strategy delivered; CFO search continues

James Routh became CEO on 1 January 2026 and set up a refreshed leadership team and new operating model. The CFO and three senior executives left on 31 July 2026. Chris Gilbert joined as Interim CFO on 1 Sept 2026, off the Board. The strategy update comes at the Capital Markets Event.

Reset
New operating model and refreshed high performance leadership team
Next milestone
Capital Markets Event, later in September 2026 (24 September 2026) 9 Sep 2026 ↗
CFO exit
Ian Melling leaves 31 July 2026; search under way, interim finance leadership update to follow 24 Jul 2026 ↗
Other exits
Michael Koch, Jane Brisley and Andrew Hanson leave 31 July 2026 24 Jul 2026 ↗
New hires
Andrew Ng, Chief Commercial Officer (May 2026); Daniel Diffenderfer, MD Medical (July 2026) 24 Jul 2026 ↗
Board
Maria Antoniou joins 1 Sept 2026 9 Sep 2026 ↗

Next: permanent CFO appointment not stated

  1. 24 Sep 2026 Strategy delivered; CFO search continues
  2. 9 Sep 2026 Interim CFO in post; permanent CFO search continues
  3. 24 Jul 2026 Leadership overhaul continues; CFO search open
  4. 7 Jul 2026 Reset under way; event date set
Open the full view – chart and every step →
Turnaround plan with targets

Profit Improvement Plan

Folded into five-year Optimise plan

The Profit Improvement Plan, launched in December 2025, targets at least £10m annual savings. The 10% headcount reduction is now complete, with initial benefits seen in Q4. Full savings are expected in FY 2027. Kleiss Gears was sold on 7 Aug 2026 with a c£3m exceptional loss.

Savings target
At least £10m annualised, delivered in FY 2027 9 Sep 2026 ↗
Cash cost
Up to £10m exceptional, mainly FY 2026
Headcount
10% reduction completed 9 Sep 2026 ↗
Extra charge
Up to £10m non-cash in H2 2026 from portfolio simplification
Next milestone
Capital Markets Event, September 2026 9 Sep 2026 ↗
Kleiss disposal
Completed 7 August 2026; c£3m exceptional loss 9 Sep 2026 ↗

Next: deliver Optimise targets: gross margin c.50% by FY31

  1. 24 Sep 2026 Folded into five-year Optimise plan
  2. 9 Sep 2026 Headcount cut done; early savings in Q4
  3. 7 Jul 2026 On track; most leavers gone in Q3
  4. 11 May 2026 Progressing; c10% roles cut, savings from late H2
Open the full view – chart and every step →

Closed · 2

Insider conviction1 director buying £45k in 2 buys · 17 Dec 2025 – 18 Mar 2026 −4% Insider conviction3 directors buying £138k in 3 buys · 1 Aug 2024 – 11 Dec 2024 −9%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note